Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage

Raquel Boia, Filipe Elvas, Maria H. Madeira, Inês D. Aires, Ana C. Rodrigues-Neves, Pedro Tralhão, Eszter C. Szabó, Younis Baqi, Christa E. Müller, Ângelo R. Tomé, Rodrigo A. Cunha, António F. Ambrósio, Ana R. Santiago*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage'. Together they form a unique fingerprint.

Medicine & Life Sciences